TRDA
Price
$12.69
Change
+$0.15 (+1.20%)
Updated
Jan 17 closing price
Capitalization
474.86M
53 days until earnings call
XERS
Price
$3.20
Change
-$0.02 (-0.62%)
Updated
Jan 17 closing price
Capitalization
477.06M
46 days until earnings call
Ad is loading...

TRDA vs XERS

Header iconTRDA vs XERS Comparison
Open Charts TRDA vs XERSBanner chart's image
Entrada Therapeutics
Price$12.69
Change+$0.15 (+1.20%)
Volume$106.64K
Capitalization474.86M
Xeris Biopharma Holdings
Price$3.20
Change-$0.02 (-0.62%)
Volume$893.05K
Capitalization477.06M
TRDA vs XERS Comparison Chart
Loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRDA vs. XERS commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a Hold and XERS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (TRDA: $12.69 vs. XERS: $3.20)
Brand notoriety: TRDA and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 87% vs. XERS: 58%
Market capitalization -- TRDA: $474.86M vs. XERS: $477.06M
TRDA [@Biotechnology] is valued at $474.86M. XERS’s [@Biotechnology] market capitalization is $477.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 0 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • TRDA’s FA Score: 0 green, 5 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than XERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 3 TA indicator(s) are bullish while XERS’s TA Score has 1 bullish TA indicator(s).

  • TRDA’s TA Score: 3 bullish, 4 bearish.
  • XERS’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than XERS.

Price Growth

TRDA (@Biotechnology) experienced а -13.38% price change this week, while XERS (@Biotechnology) price change was -5.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

TRDA is expected to report earnings on May 08, 2025.

XERS is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XERS($477M) and TRDA($475M) have the same market capitalization . XERS YTD gains are higher at: -5.605 vs. TRDA (-26.605). TRDA has higher annual earnings (EBITDA): 61.3M vs. XERS (-23.07M). TRDA has more cash in the bank: 449M vs. XERS (69.4M). TRDA has less debt than XERS: TRDA (61.3M) vs XERS (271M). TRDA has higher revenues than XERS: TRDA (215M) vs XERS (187M).
TRDAXERSTRDA / XERS
Capitalization475M477M100%
EBITDA61.3M-23.07M-266%
Gain YTD-26.605-5.605475%
P/E Ratio8.81N/A-
Revenue215M187M115%
Total Cash449M69.4M647%
Total Debt61.3M271M23%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TRDAXERS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
82%
Momentum
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 11 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
87%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 12 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGDMX112.351.05
+0.94%
Fidelity Advisor Communication ServicesA
ISGNX15.670.12
+0.77%
Columbia Integrated Small Cap Gr Instl
NIEAX14.880.11
+0.74%
BNY Mellon International Equity A
TEMTX25.620.12
+0.47%
Franklin Mutual Shares C
INFFX9.940.01
+0.10%
Tortoise Energy Infrastructure and Inc C

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with PLRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+1.20%
PLRX - TRDA
52%
Loosely correlated
-3.36%
RXRX - TRDA
48%
Loosely correlated
+2.03%
CRNX - TRDA
47%
Loosely correlated
+2.38%
MGTX - TRDA
47%
Loosely correlated
+5.56%
STRO - TRDA
46%
Loosely correlated
+8.65%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
-0.62%
TRDA - XERS
45%
Loosely correlated
+1.20%
SCPH - XERS
44%
Loosely correlated
-4.09%
FHTX - XERS
40%
Loosely correlated
+2.62%
CRSP - XERS
40%
Loosely correlated
+0.57%
IMNM - XERS
39%
Loosely correlated
+1.32%
More